If you would like to submit a blog post for consideration, please email email@example.com
[6 min watch] Topical ivermectin an off-label alternative to treat neonatal scabies
In this short video, Dr Vincenzo Piccolo looks at recent research he conducted with colleagues into the use of topical ivermectin as an off-label alternative to treat neonatal scabies.
For further information on this topic, you may be interested to learn more about the HealthCert Professional Diploma program in General Dermatology.
In previous research, Dr Piccolo looked at evidence that the standard protocol of permethrin therapy is becoming less effective in the treatment of scabies. Among patients who were unresponsive to permethrin therapy, Dr Piccolo and his colleagues trialed other therapies, including topical ivermectin.
In this latest research review, Dr Piccolo looks at the results of the new study into topical ivermectin as an off-label alternative to treat permethrin-resistant scabies in two newborns.
The treatment is already utilised to treat scabies and rosacea in adult patients, but is not a standard treatment in patients under 15 kilograms, who can therefore be difficult to treat.
Complete clinical and dermoscopic resolution was achieved in both newborns after one week.
2 comments on “[6 min watch] Topical ivermectin an off-label alternative to treat neonatal scabies”